42 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
1
Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
National and Kapodistrian University of Athens
7
Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrinavß3.
University of California
17
Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase.
Peking University
4
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
Istituto Per La Chimica Di Molecole Di Interesse Biologico Cnr
3
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
University of Salerno
24
Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.
Shionogi
16
Quinoline-4-methyl esters as human nonpancreatic secretory phospholipase A2 inhibitors.
Peking University
7
Inhibition of secreted phospholipases A2 by 2-oxoamides based ona-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.
University of Athens
32
Design of new potent and selective secretory phospholipase A(2) inhibitors. 6-Synthesis, structure-activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives.
Paris Diderot University
3
Analogs of the marine natural product scalaradial lacking the α,β-unsaturated aldehyde: effects on human synovial fluid phospholipase A2 and macrophage lipid mediator production
TBA
4
Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.
Peking University
15
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
University of Washington
23
Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.
University of Washington
3
New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.
Università
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
Johann Wolfgang Goethe University
24
Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.
Université
52
Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development.
University of Nottingham
17
Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-
Prince Sattam Bin Abdulaziz University
44
Recent advancements in the development of heterocyclic anti-inflammatory agents.
Isf College of Pharmacy
4
The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding.
University of Washington
28
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities.
Niddk
147
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.
Central South University
18
Novel 3-dodecanoylindole-2-carboxylic acid inhibitors of cytosolic phospholipase A(2).
University of MüNster
6
Synthesis and enzyme inhibitory activities of a series of lipidic diamine and aminoalcohol derivatives on cytosolic and secretory phospholipases A2.
Univ. De Valencia
6
Synthesis and PLA2-inhibitory properties of 2(R)-acetamido-alkylphosphomethanols with a variable aggregate anchor.
Tumor Biology Center
6
Design and synthesis of new secretory phospholipase A2 inhibitor of a phospholipid analog.
Kwansei Gakuin University
74
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
Eli Lilly
45
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides.
Eli Lilly
85
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality.
Eli Lilly
2
N-(carboxymethyl)-N-[3,5-bis(decyloxy)-phenyl]glycine (Ro 23-9358): a potent inhibitor of secretory phospholipases A2 with antiinflammatory activity.
Roche Research Center
14
Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2.
Fisons
27
Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A
AstraZeneca
3
MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF
Insilico Medicine IP